Rast, Jessica E. http://orcid.org/0000-0002-1381-130X
Tao, Sha
Schott, Whitney http://orcid.org/0000-0001-9303-8718
Shea, Lindsay L. http://orcid.org/0000-0003-0610-0355
Brodkin, Edward S. http://orcid.org/0000-0003-1417-7838
Kerns, Connor M. http://orcid.org/0000-0003-0832-8329
Leonard, Charles E. http://orcid.org/0000-0002-5092-9657
Murray, Michael J.
Lee, Brian K. http://orcid.org/0000-0002-3635-8034
Funding for this research was provided by:
Pennsylvania Department of Health (4100085747)
Health Resources and Services Administration (UT2MC39440)
National Institutes of Health (R01AG060975)
Michael Smith Health Research BC (SCH-2021-1709)
Canadian Foundation for Innovation (38787)
Article History
Accepted: 3 November 2023
First Online: 18 December 2023
Declarations
:
: Dr. Leonard is an Executive Committee Member of the University of Pennsylvania’s Center for Real-World Effectiveness and Safety of Therapeutics. The Center receives funds from Pfizer and Sanofi to support pharmacoepidemiology education. He is a Special Government Employee of the US Food and Drug Administration. He consults for Novo Nordisk and TriNetX. He recently received an honorarium from the American College of Clinical Pharmacy Foundation. His spouse is employed by Merck; neither he nor she own stock in the company.